Related Experiment Video
Updated: Mar 11, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Natural Products with Antiplatelet Action
Gabriela Elisa Hirsch1, Paulo Ricardo Nazario Viecili1, Amanda Spring de Almeida1
1Programa de Pós-Graduação em Atenção Integral à Saúde (PPGAIS), Universidade de Cruz Alta (UNICRUZ), 98020-290 Cruz Alta, RS. Brazil.
Medicinal plants like saffron and garlic can inhibit platelet aggregation, a key factor in cardiovascular diseases. These natural compounds offer potential for developing new antiplatelet drugs.
Area of Science:
- Pharmacology
- Cardiovascular Science
- Phytochemistry
Background:
- Platelet aggregation is a critical factor in cardiovascular diseases such as atherosclerosis.
- Dysregulation of platelet activity, including aggregation and reduced blood flow, contributes to disease progression.
- Key platelet activation pathways involve arachidonic acid, adenosine diphosphate, serotonin, nitric oxide, and free radical actions.
Purpose of the Study:
- To review medicinal plants with antiplatelet activity.
- To identify phytochemical components responsible for antiplatelet effects.
- To explore the potential of these plants in complementary and alternative medicine for cardiovascular health.
Main Methods:
- Literature review of studies on medicinal plants and their effects on platelet aggregation.
- Identification of plants with documented antiplatelet properties.
- Analysis of phytochemical constituents linked to antiplatelet activity.
Main Results:
- Several medicinal plants, including saffron, garlic, green tea, St. John's wort, ginger, ginkgo biloba, ginseng, and guavirova, exhibit antiplatelet activity.
- Phytochemicals such as flavonoids, curcumins, catechins, terpenoids, polyphenols, and saponins are associated with the observed antiplatelet effects.
- These plants are found globally, with a majority originating from Asia.
Conclusions:
- Medicinal plants and their compounds demonstrate significant antiplatelet activity.
- These natural agents represent promising candidates for the development of novel therapeutic agents.
- Further research into these plants could lead to new treatments for aggregation-related disorders.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

